The New York Times

Erin Lee Carr’s new documentary revisits the 2004 makeover show “The Swan,” which gave 32 women extensive plastic surgery and anticipated where beauty culture was headed.

Researchers are asking why patients, like former Senator Ben Sasse, inevitably develop resistance to the drug daraxonrasib.

Epic’s engineers deployed an Anthropic tool that exposed security risks that could allow undetected access to millions of patient records.

Targeted gene therapies are highly effective at stopping cancers, but the very abundance of the treatments, plus cost and sluggish change, are hindering access.

The health secretary, Vice President JD Vance and other top officials addressed a conference sponsored by corporations, including A.I. companies and others with business before the government.

Veterans under 30 will have to sign forms before being given antidepressants. Medical groups fear the moves may stigmatize mental health treatment.

Scientists have found a human gene lurking in a virus that causes skin infections. It may be using our own DNA to infect us.

State health officials said 55 new cases had been reported since Wednesday. In all, 890 measles cases have been reported across 39 counties so far this year.

The agency has lost its independence and nearly a third of its staff, as Health Secretary Robert F. Kennedy Jr. and associates have tightened control.

Most member nations spoke in support of the declaration, but some rich countries had strong objections.

“Patient zero” has long been associated with virus outbreaks and fictional health investigations. It was coined in the 1980s, by accident.

Scientists at the company announced their first finding: a group of enzymes whose function is unknown.

The use of artificial intelligence by hospitals and health insurers is escalating their longstanding feud over paying for medical care.

Dr. Heidi Overton has called mifepristone “dangerous to women.” As a White House aide, she worked to reduce the number of vaccines recommended for children.

For 10 years Jennifer Koh struggled to understand and treat a rare neurological disorder, while trying to maintain a full calendar onstage.